In a report released today, Swayampakula Ramakanth from H.C. Wainwright reiterated a Buy rating on AVEO Pharma (AVEO – Research Report), with a price target of $19.00. The company's shares closed last Thursday at $4.61. According to TipRanks.com, Ramakanth is a 3-star analyst with an average return of 1.2% and a 33.3% success rate. Ramakanth covers the Healthcare sector, focusing on stocks such as Diffusion Pharmaceuticals, Corvus Pharmaceuticals, and Janux Therapeutics Inc. The word on The Street in general, suggests a Strong Buy analyst consensus rating for AVEO Pharma with a $15.75 average price target.
https://www.tipranks.com/news/blurbs/aveo-pharma-aveo-gets-a-buy-rating-from-h-c-wainwright?utm_source=advfn.com&utm_medium=referral
AVEO Pharmaceuticals (NASDAQ:AVEO)
Historical Stock Chart
From Nov 2022 to Dec 2022 Click Here for more AVEO Pharmaceuticals Charts.
AVEO Pharmaceuticals (NASDAQ:AVEO)
Historical Stock Chart
From Dec 2021 to Dec 2022 Click Here for more AVEO Pharmaceuticals Charts.